Evidence map›Paper›PMID 41399485›Full record

ArticleJournal of pharmaceutical analysis2025

VLDL: The key factors influencing the distribution of mitotane in patients with adrenocortical carcinoma.

Xiangjie Di, Yixian Liu, Jia You, Yuchun Men, Zhenlei Wang, Chao Zhou, Ying Jin, Yating Ge, Yongji He, Li Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiangjie DiCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yixian LiuCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Jia YouCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yuchun MenCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zhenlei WangCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Chao ZhouSCIEX China, Shanghai, 200335, China.
Ying JinCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yating GeCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yongji HeCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li ZhengCancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Image 1.

Identifiers

PMID41399485
PMCPMC12702426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.